205 related articles for article (PubMed ID: 35040787)
21. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
[TBL] [Abstract][Full Text] [Related]
22. Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
Low EXS; Wang YP; Lu CL
Dig Dis Sci; 2024 Jan; 69(1):7-9. PubMed ID: 37968555
[TBL] [Abstract][Full Text] [Related]
23. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis.
Ma YJ; Cao ZX; Li Y; Feng SY
World J Gastroenterol; 2019 Jun; 25(21):2675-2682. PubMed ID: 31210718
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies.
Wu X; Zhang D; Yu Y; Lou L; Li X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32406491
[TBL] [Abstract][Full Text] [Related]
26. Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis.
Hung TH; Tseng CW; Lee HF; Tsai CC; Tsai CC
Ann Hepatol; 2018 Oct; 17(6):933-939. PubMed ID: 30600287
[TBL] [Abstract][Full Text] [Related]
27. Infection risk and management strategies for patients with cirrhosis taking proton pump inhibitors.
Zerr B; Vazquez A; Erstad BL
Am J Health Syst Pharm; 2023 Jul; 80(15):967-973. PubMed ID: 37105716
[TBL] [Abstract][Full Text] [Related]
28. Deleterious effect of proton pump inhibitors on the disease course of cirrhosis.
Janka T; Tornai T; Borbély B; Tornai D; Altorjay I; Papp M; Vitális Z
Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):257-264. PubMed ID: 31464790
[TBL] [Abstract][Full Text] [Related]
29. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.
Kwon JH; Koh SJ; Kim W; Jung YJ; Kim JW; Kim BG; Lee KL; Im JP; Kim YJ; Kim JS; Yoon JH; Lee HS; Jung HC
J Gastroenterol Hepatol; 2014 Apr; 29(4):775-81. PubMed ID: 24219827
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
[TBL] [Abstract][Full Text] [Related]
31. Proton Pump Inhibitor Use and Complications of Cirrhosis Are Linked With Distinct Gut Microbial Bacteriophage and Eukaryotic Viral-Like Particle Signatures in Cirrhosis.
Peña Rodríguez M; Fagan A; Sikaroodi M; Gillevet PM; Bajaj JS
Clin Transl Gastroenterol; 2024 Feb; 15(2):e00659. PubMed ID: 37937851
[TBL] [Abstract][Full Text] [Related]
32. The impact of proton pump inhibitors in liver diseases and the effects on the liver.
Liu YB; Chen MK
J Dig Dis; 2022 Apr; 23(4):196-208. PubMed ID: 35357775
[TBL] [Abstract][Full Text] [Related]
33. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
[TBL] [Abstract][Full Text] [Related]
34. Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites.
Dam G; Vilstrup H; Andersen PK; Bossen L; Watson H; Jepsen P
Liver Int; 2019 Mar; 39(3):514-521. PubMed ID: 30472808
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis.
Leache L; Gutiérrez-Valencia M; Saiz LC; Uriz J; Bolado F; García-Erce JA; Cantarelli L; Erviti J
Aliment Pharmacol Ther; 2023 Mar; 57(6):620-634. PubMed ID: 36524316
[TBL] [Abstract][Full Text] [Related]
36. Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
Nardelli S; Gioia S; Ridola L; Farcomeni A; Merli M; Riggio O
Hepatology; 2019 Aug; 70(2):640-649. PubMed ID: 30289992
[TBL] [Abstract][Full Text] [Related]
37. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
38. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.
Deshpande A; Pasupuleti V; Thota P; Pant C; Mapara S; Hassan S; Rolston DD; Sferra TJ; Hernandez AV
J Gastroenterol Hepatol; 2013 Feb; 28(2):235-42. PubMed ID: 23190338
[TBL] [Abstract][Full Text] [Related]
39. Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysis.
Wang J; Wu Y; Bi Q; Zheng X; Zhang J; Huang W
Hepatol Int; 2020 May; 14(3):385-398. PubMed ID: 31912308
[TBL] [Abstract][Full Text] [Related]
40. Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis.
Lachar J; Bajaj JS
Semin Liver Dis; 2016 Sep; 36(4):327-330. PubMed ID: 27997972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
